Opsonization of Cryptococcus neoformans by human anticryptococcal glucuronoxylomannan antibodies

Infection and Immunity

Volumn 64, Issue 9, 1996, Pages 3446-3450

  Zhong, Zhaojing ^a   Pirofski, Liise Anne ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DEPENDENT LYMPHOCYTOTOXICITY; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; COMPLEMENT ACTIVATION; CRYPTOCOCCUS NEOFORMANS; EFFECTOR CELL; FUNGAL MENINGITIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL;

EID: 0029850607     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.9.3446-3450.1996     Document Type: Article

References (44)

1. Berger, M., T. M. Norvell, M. F. Tosi, S. N. Emancipator, M. W. Konstan, and J. R. Schreiber. 1994. Tissue-specific Fc gamma and complement receptor expression by alveolar macrophages determines relative importance of IgG and complement in promoting phagocytosis of Pseudomonas aeruginosa. Pediatr. Res. 35:68-77.
2. Bjerknes, R., C. F. Bassoe, H. Sjursen, O. D. Laerum, and C. O. Solberg. 1989. Flow cytometry for the study of phagocyte functions. Rev. Infect. Dis. 11:16-24.
3. Casadevall, A., and M. D. S. Scharff. 1994. Serum therapy revisited: animal models of infection and the development of passive antibody therapy. Antimicrob. Agents Chemother. 38:1695-1702.
4. Collins, H. L., and G. J. Bancroft. 1992. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 22:1447-1454.
5. Curric, B. P., and A. Casadevall. 1994. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin. Infect. Dis. 19:1029-1033.
6. Davies, S. F., D. P. Clifford, J. R. Hoidal, and J. E. Repine. 1982. Opsonic requirements for the uptake of Cryptococcus neoformans by human polymorphonuclear leukocytes and monocytes. J. Infect. Dis. 145:870-874.
7. DeShaw, M., and L. Pirofski. 1995. Antibodies to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan are ubiquitous in the serum of HIV+ and HIV- individuals. Clin. Exp. Immunol. 99:425-432.
8. Devi, S. G. N., R. Schneerson, W. Egan, T. J. Ulrich, D. Bryla, J. B. Robbins, and J. E. Bennett. 1991. Cryptococcus neoformans serotype A glucuronoxy-lomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect. Immun. 59:3700-3707.
9. Diamond, R. D. 1974. Antibody-dependent killing of Cryptococcus neoformans by human peripheral blood mononuclear cells. Nature (London) 247: 148-150.
10. Diamond, R. D., and J. E. Bennett. 1974. Prognostic factors in cryptococcal meningitis. Ann. Intern. Med. 80:176-181.
11. Diamond, R. D., J. E. May, M. A. Kane, M. M. Frank, and J. E. Bennett. 1974. The role of the classical and alternative complement pathways in host defenses against Cryptococcus neoformans infection. J. Immunol. 112:2260-2270.
12. Drevets, D. A., and P. A. Campbell. 1991. Macrophage phagocytosis: use of fluorescence microscopy to distinguish between extracellular and intracellular bacteria. J. Immunol. Methods 142:31-38.
13. Dromer, F., P. Aucouturier, J. Clauvel, G. Saimol, and P. Yeni. 1988. Cryptococcus neoformans antibody levels in patients with AIDS. Scand. J. Infect. Dis. 20:283-285.
14. Fothergill, L. D., and J. Wright. 1933. Influenzal meningitis: relation of age incidence to the bactericidal power of blood against the causal organism. J. Immunol. 24:273-284.
15. Goldschneider, I., E. C. Gotschlich, and M. S. Artenstein. 1969. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1307-1326.
16. Griffin, F. M., Jr. 1981. Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans. Proc. Natl. Acad. Sci. USA 78:3853-3857.
17. Hobbs, M. M., J. R. Perfect, D. L. Granger, and D. T. Durack. 1990. Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis. Infect. Immun. 58:2115-2119.
18. Houpt, D. C., T. Pfrommer, B. Young, T. A. Larson, and T. R. Kozel. 1994. Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan. Infect. Immun. 62:2857-2864.
19. Indik, Z. K., J. G. Park, X. Q. Pan, and A. D. Schreiber. 1995. Induction of phagocytosis by a protein tyrosine kinase. Blood 85:1175-1180.
20. Jarvis, G. A., and J. M. Griffls. 1991. Human IgAl blockade of IgG-initiated lysis of Neisseria meningitidis is a function of Fab binding to the polysaccharide capsule. J. Immunol. 147:1962-1967.
21. Kozel, T. R. 1993. Opsonization and phagocytosis of Cryptococcus neoformans. Arch. Med. Res. 24:211-218.
22. Kozel, T. R., and E. C. Gotschlich. 1982. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J. Immunol. 129:1675-1680.
23. Kozel, T. R., and T. G. McGaw. 1979. Opsonization of Cryptococcus neoformans by human immunoglobulin O role of immunoglobulin G in phagocytosis by macrophages. Infect. Immun. 18:701-707.
24. Kozel, T. R., G. S. T. Pfrommer, A. S. Guerlain, B. A. Highison, and G. J. Highison. 1988. Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev. Infect. Dis. 10:8436-5439.
25. Kozlowski, P. A., B. P. Kelley, L. Shen, and S. Jackson. 1996. High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. J. Immunol. 154:6163-6173.
26. Levite, S. M., and T. P. Karrell. 1990. Growth inhibition of Cryptococcus neofomwns by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines. Infect. Immun. 58:1201-1209.
27. Levitz, S. M, T. P. Farrell, and R. T. Maziarz. 1990. Killing of Cryptococcus neoformans by peripheral blood mononuclear cells stimulated in culture. J. Infect. Dis. 163:1108-1113.
28. Levitz, S. M., and A. Tabuni. 1991. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. J. Clin. Invest. 87:528-535.
29. Lortan, J. E., A. S. Kanuik, and M. A. Monteil. 1993. Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults. Clin. Exp. Immunol. 91:54-57.
30. Macher, A. M., J. E. Bennett, J. D. Gadek, and M. M. Frank. 1978. Complement depletion in cryptococcal sepsis. J. Immunol. 120:1686-1690.
31. MacLeod, C. M., R. G. Hodges, M. Heidelberger, and W. G. Berhnard. 1945. Prevention of pneumococcal pneumonia by immunization with specific polysaccharides. J. Exp. Med. 82:445-465.
32. Mozaffarian, N., J. W. Berman, and A. Casadevall. 1995. Immune complexes increase nitric oxide production by interferon-gamma-stimulated murine macrophage-like J774.16 cells. J. Leukocyte Biol. 57:657-662.
33. Mukherjee, J., L. Pirofski, M. D. Scharff, and A. Casadevall. 1993. Antibodymediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc. Natl. Acad. Sci. USA 90:3636-3640.
34. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534-4541.
35. Mukherjee, S., S. Lee, J. Mukherjee, M. D. Scharff, and A. Casadevall. 1994. Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice. Infect. Immun. 62:1079-1088.
36. Mukherjee, S., S. C. Lee, and A. Casadevall. 1995. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect. Immun. 63:573-579.
37. Ohno, T., H. Kubagawa, S. K. Sanders, and M. D. Cooper. 1990. Biochemical nature of an Fc mu receptor on human B-lineage cells. J. Exp. Med. 172:1165-1175.
38. Pirofski, L., and A. Casadevall. 1996. Cryptococcus neoformans: paradigm for the role antibody in immunity. Zentralbl. Bakteriol., in press.
39. Pirofski, L., R. Lui, M. DeShaw, A. B. Kressel, and Z. Zhong. 1995. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Infect. Immun. 63:3005-3014.
40. Robbins, J. B., R. Schneerson, and S. C. Szu. 1995. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1387-1398.
41. Sanford, J. E., D. M. Lupan, A. M. Schalgeter, and T. R. Kozel. 1990. Passive immunization against Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide. Infect. Immun. 58:1919-1923.
42. Schlageter, A. M., and T. R. Kozel. 1990. Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide. Infect. Immun. 58:1914-1918.
43. Wallace, P. K., A. L. Howell, and M. W. Fanger. 1994. Role of Fc(gamma) receptors in cancer and infectious diseases. J. Leukocyte Biol. 55:816-826.
44. Yuan, R., A. Casadevall, G. Spira, and M. D. Scharff. 1995. Isotype switching from IgG3 to IgG1 converts a nonprotective antibody murine antibody to Cryptococcus neoformans to a protective antibody. J. Immunol. 154:1810-1815.